CUSABIO
PrivateLast Round
Series E
Aug 18, 2025
Est. Valuation
$872M
Total Funding Raised
$25M
Company Overview
CUSABIO is a biotechnology company that manufactures and supplies raw materials for the in vitro diagnostic (IVD) industry, including proteins, antibodies, and enzymes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CUSABIO Comparables
Compare CUSABIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medix Biochemica | 87% | |
| BBI Solutions | 81% | |
| Sino Biological Inc. | 80% |
CUSABIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Aug 18, 2025 | ||||
| Series C | May 17, 2021 | ||||
| Capitalization | Apr 16, 2019 | ||||
| Private Equity | Dec 27, 2012 | ||||
| Angel | Apr 27, 2006 |
CUSABIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guoke Private Equity Fund Management Co., Ltd. | Series C |
| CAS Star | Series C |
| Beijing Hongzhou Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2021
Raised $872M at $806.2M pre-money valuation.
- Apr 16, 2019
Completed a capitalization funding round.
CUSABIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CUSABIO's valuation, stock price, and market status.
Is CUSABIO a public or private company?
CUSABIO is a private company.
What is the current stock price of CUSABIO?
CUSABIO is a private company, so its shares have no public market price. Caplight tracks CUSABIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CUSABIO worth (valuation)?
CUSABIO's valuation is estimated at $872.0M based on funding round data.
Can I buy CUSABIO stock?
CUSABIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CUSABIO's last funding round?
CUSABIO's most recent funding round was Series E on August 18, 2025.
Who are the main investors in CUSABIO?
Key investors in CUSABIO include Guoke Private Equity Fund Management Co., Ltd., CAS Star, Beijing Hongzhou Investment.
Will CUSABIO IPO soon?
No public IPO plans have been announced for CUSABIO.
How can I track CUSABIO secondary market activity?
Caplight tracks bids, offers, and trades in CUSABIO's shares on secondary markets.